Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Maureen Okam Achebe, MD, MPH
Healthcare Provider Clinical Director
Non-Malignant Hematology Clinic
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts, United States
Dr. Maureen M. Okam studied medicine at University of Port Harcourt Medical School (1995). Her interests are hematologic disorders, anemia, sickle cell disease and thalassemia, thrombosis and anticoagulant therapy, thrombocytopenia, myelodysplasia and myeloproliferative disorders.
Her current research focuses on the pre-clinical and clinical development of new agents for the treatment of hemoglobinopathies – sickle cell disease and thalassemia. Her on-going clinical evaluation of histone deacetylase inhibitors in the induction of fetal hemoglobin, is funded by the National Institutes of Health through a Harvard Blood Scholars research grant.
Appointments:
Clinical Director, Non-Malignant Hematology Clinic
Assistant Director, Brigham and Women’s Hospital Outpatient Infusion Center
Director, Brigham and Women’s Hospital Sickle Cell Program
Assistant Professor in Medicine, Harvard Medical School
Related Content
-
Marina Cavazzana, MD, PhDMarina Cavazzana is a pediatrician, Prof...
-
Sickle cell disease in childrenSickle cell disease (SCD) is an inherite...
-
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful CrisesOBJECTIVES: Sickle cell disease is the ...
-
Simon Dyson, PhDSimon Dyson is Professor of Applied Soci...
-
Children’s National Health SystemSickle cell disease affects many familie...
-
California Sickle Cell ResourcesThe Comprehensive Sickle Cell Center at ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...